MDT

85.25

-1.98%↓

112.89

+0.95%↑

VEEV

175.24

-0.3%↓

HQY

82.47

-0.59%↓

CSBR

5.65

-0.18%↓

MDT

85.25

-1.98%↓

112.89

+0.95%↑

VEEV

175.24

-0.3%↓

HQY

82.47

-0.59%↓

CSBR

5.65

-0.18%↓

MDT

85.25

-1.98%↓

112.89

+0.95%↑

VEEV

175.24

-0.3%↓

HQY

82.47

-0.59%↓

CSBR

5.65

-0.18%↓

MDT

85.25

-1.98%↓

112.89

+0.95%↑

VEEV

175.24

-0.3%↓

HQY

82.47

-0.59%↓

CSBR

5.65

-0.18%↓

MDT

85.25

-1.98%↓

112.89

+0.95%↑

VEEV

175.24

-0.3%↓

HQY

82.47

-0.59%↓

CSBR

5.65

-0.18%↓

Home・Akciju saraksts・Inmode Ltd

Inmode Ltd

Atvērts

SektorsVeselības aprūpe

13.51 0.67

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

13.19

Max

13.64

Galvenie mērījumi
By Trading Economics
Ienākumi	5.2M 27M
Pārdošana	11M 104M
P/E Sektora vidējais	9.601 57.05
Peļņas marža	26.022
Darbinieki	660
EBITDA	5.7M 31M

Rekomendācijas
By TipRanks
Rekomendācijas	Neitrāls
Prognoze 12 mēnešiem	+31.87% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 27. apr.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-156M 870M
Iepriekšējā atvēršanas cena	12.84
Iepriekšējā slēgšanas cena	13.51

Ziņu noskaņojums

By Acuity

50%

169 / 349 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

14.1 / 14.44 Atbalsts un pretestība

Inmode Ltd Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 30. marts 23:15 UTC

Galvenie ziņu notikumi

U.K. Shoppers Paid a Little More This Month But Worse May yet Lie Ahead

2026. g. 30. marts 22:36 UTC

Galvenie ziņu notikumi

Australian Government Rules Out Boots on the Ground in the Middle East

2026. g. 30. marts 22:13 UTC

Iegādes, apvienošanās, pārņemšana

Sun Life Financial Agrees to Buy Bell Partners for $350 Million

2026. g. 30. marts 21:00 UTC

Peļņas

Aktis Oncology Gets FDA Clearance for Phase 1 Billion Trial of Tumor Treatment

2026. g. 30. marts 20:15 UTC

Galvenie ziņu notikumi

Fed's Williams: Middle-East Developments Have Added Significant Economic Uncertainty

2026. g. 30. marts 23:40 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 30. marts 23:40 UTC

Tirgus saruna

Nikkei May Decline on Higher Energy Cost Concerns -- Market Talk

2026. g. 30. marts 23:36 UTC

Tirgus saruna

Gold Edges Lower Amid Divergent Signals on U.S.-Iran Talks -- Market Talk

2026. g. 30. marts 23:12 UTC

Tirgus saruna

Alcoa Earnings Outlook Boosted by Market Disruptions -- Market Talk

2026. g. 30. marts 22:49 UTC

Tirgus saruna

Fed's Williams: Core Inflation Forecast Is Little Changed -- Market Talk

2026. g. 30. marts 22:44 UTC

Tirgus saruna

Fed's Williams: Risks to Both Sides of Dual Mandate Higher -- Market Talk

2026. g. 30. marts 22:43 UTC

Tirgus saruna

Fed's Williams Says Focus Is on Inflation Expectations Being Well Anchored -- Market Talk

2026. g. 30. marts 22:42 UTC

Tirgus saruna

South32 Should Go for Growth, Says New Bull -- Market Talk

2026. g. 30. marts 22:18 UTC

Tirgus saruna

Paragon Care's Chances of Using Levy to Pass on Higher Costs `Close to Zero' -- Market Talk

2026. g. 30. marts 22:05 UTC

Tirgus saruna

Northern Star's New Bull Argues Case for Asset Sales -- Market Talk

2026. g. 30. marts 21:58 UTC

Iegādes, apvienošanās, pārņemšana

Sun Life Financial Agrees to Buy Bell Partners for $350M

2026. g. 30. marts 21:39 UTC

Iegādes, apvienošanās, pārņemšana

Sun Life Sees 1Q Charge to Net of C$236M From BGO, Crescent Deals

2026. g. 30. marts 21:38 UTC

Iegādes, apvienošanās, pārņemšana

Sun Life: Completes Remaining Equity Interest Purchases of BGO, Crescent Capital

2026. g. 30. marts 21:36 UTC

Iegādes, apvienošanās, pārņemšana

Sun Life to Buy Fully Bell Partners for $350M >SLF.T

2026. g. 30. marts 21:33 UTC

Iegādes, apvienošanās, pārņemšana

Unilever Shareholders Expected to Own Two-Thirds of New Food Entity, Sources Say -- WSJ

2026. g. 30. marts 21:33 UTC

Iegādes, apvienošanās, pārņemšana

Unilever Nears Deal to Create $60 Billion Food Giant With McCormick -- WSJ

2026. g. 30. marts 21:33 UTC

Iegādes, apvienošanās, pārņemšana

Deal Could Be Announced As Soon As Tuesday, Sources Say -- WSJ

2026. g. 30. marts 21:33 UTC

Iegādes, apvienošanās, pārņemšana

Unilever Nears Cash-and-Stock Deal to Combine Food Business With McCormick, Sources Say -- WSJ

2026. g. 30. marts 21:33 UTC

Iegādes, apvienošanās, pārņemšana

Deal Set to Value Combined Food Business At Around $60B Including Debt, Sources Say -- WSJ

2026. g. 30. marts 21:25 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 30. marts 21:25 UTC

Tirgus saruna

Warehouse Showing Cost Discipline But Margin Goal at Risk -- Market Talk

2026. g. 30. marts 21:03 UTC

Iegādes, apvienošanās, pārņemšana

Sun Life: Completes Equity Interest Purchases of BGO and Crescent Cap, Announces Acquisition of Bell Partners, a Multifamily Real Estate Investment Manager

2026. g. 30. marts 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 30. marts 20:09 UTC

Peļņas

This Stock Looks Like a Solid AI Bet -- and Wall Street Hasn't Noticed Yet -- Barrons.com

2026. g. 30. marts 20:00 UTC

Galvenie ziņu notikumi

Fed's Williams: Middle-East Conflict 'Will Likely Boost Overall Inflation in Coming Months'

Salīdzinājums

Cenas izmaiņa

Inmode Ltd Prognoze

Cenas mērķis

By TipRanks

31.87% augšup

Prognoze 12 mēnešiem

Vidējais 17.67 USD 31.87%

Augstākais 21 USD

Zemākais 15 USD

Pamatojoties uz 5 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Inmode Ltd — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

5 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 5 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Inmode Ltd — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

14.1 / 14.44Atbalsts un pretestība

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Noskaņojums

By Acuity

169 / 349 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Inmode Ltd

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.